Back to Journals » International Journal of Nanomedicine » Volume 14

Smart nanomedicine agents for cancer, triggered by pH, glutathione, H2O2, or H2S

Authors Li Y, An L, Lin J, Tian Q, Yang S

Received 26 March 2019

Accepted for publication 23 May 2019

Published 24 July 2019 Volume 2019:14 Pages 5729—5749

DOI https://doi.org/10.2147/IJN.S210116

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Linlin Sun


Yaping Li,1–3 Lu An,1–3 Jiaomin Lin,1–3 Qiwei Tian,1–3 Shiping Yang1–3

1Key Laboratory of Resource Chemistry of the Ministry of Education; 2The Shanghai Key Laboratory of Rare Earth Functional Materials; 3The Shanghai Municipal Education Committee Key Laboratory of Molecular Imaging Probes and Sensors, Shanghai Normal University, Shanghai 200234, People’s Republic of China

Abstract: Effective tumor diagnosis and therapy have always been a significant but challenging issue. Although nanomedicine has shown great potential for improving the outcomes of tumor diagnosis and therapy, the nonspecial targeted distribution of nanomedicine agents in the whole body causes a low diagnosis signal-to-noise ratio and a potential risk of systemic toxicity. Recently, the development of smart nanomedicine agents with diagnosis and therapy functions that can only be activated by the tumor microenvironment (TME) is regarded as an effective strategy to improve the theranostic sensitivity and selectivity, as well as reduce the potential side effects during treatment. This article will introduce and summarize the latest achievements in the design and fabrication of TME-responsive smart nanomedicine agents, and highlight their prospects for enhancing tumor diagnosis and therapy.

Keywords: tumor microenvironment, smart nanomedicine agents, theranostic agents, smart nanoprobes, smart nanocarriers

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]